I’m pleased to announce two new specials for our Botox and filler (Juvederm, Restylane, Sculptra, etc.) patients. Special #1: Bring a Friend and Save. Book a filler or Botox appointment for yourself and a good friend at the same time. If the friend is a new patient to our practice, we’ll give you a credit of 15% […]
We’re pleased to announce a new service for our patients. We call it “Same Day Botox” – and just like the name implies, we’re opening up a limited number of appointments each day for people that want to have their treatment with Botox or any of the injectable fillers that same day. Just call early in the […]
Sculptra, the injectible PLA filler, received official FDA approval today for cosmetic use. It had initially approved several years ago for the treatment of lipo-atrophy, (most commonly seen in HIV patients) and was used on an “off-label” basis for cosmetic purposes. It’s a very useful product.Sculptra can be very helpful to restore volume loss in […]
Dysport – the recently approved competitor to Botox Cosmetic – is now being shipped to U.S. physicians. We have both products in our office now, and are testing Dysport, seeing how it compares to Botox, the market leader. So far, there are some subtle differences, but both seem to work well in relaxing dynamic wrinkles of the face.It […]
Here’s an interesting press release from ASAPS (American Society for Aesthetic Plastic Surgery), discussing a new survey in which Botox Cosmetic and fillers like Restylane and Juvederm were now “mainstream” topics of discussion amongst patients, and not any big “secret”. This matches with our experience – our female patients openly discuss their treatments, much like […]
This week, Q-Med, the Swedish pharmceutical company that is the home to Restylane and Perlane, announced Restylane® Lidocaine and Restylane Perlane™ Lidocaine as the latest additions to their Restylane family of dermal fillers. These products have the familiar Restylane and Perlane hyaluronic gel fillers, together with a small amount (0.3 %) of lidocaine, a commonly used […]
Botox competitor “Reloxin” (sold in Europe as “Dysport”) received its FDA approval today. The FDA decided to approve both the cosmetic indications (for wrinkles) and the functional indications (cervical dystonia) at the same time – and decided that the drug should be sold under the same name for both categories. So, it’s now officially “Dysport” […]
“Reloxin”, a form of botulinum toxin, and potential competition for Botox, could go on sale in the U.S. soon. The FDA is currently evaluating the product, which has been sold in Europe for approximately 15 years under the name Dysport. It’s a wrinkle-fighter, similar to Botox, and it also has a good track record of […]
